Molecular genetic factors of uterine fibroids formation
https://doi.org/10.21518/ms2025-051
Abstract
Uterine fibroids are benign tumors of the myometrium that affect more than 70% of women worldwide. Due to the high prevalence, the economic costs of the health system and the significant impact on women’s quality of life, uterine fibroids pose a serious problem both for each individual woman with this diagnosis and for the health care system as a whole. Genetic factors play a significant role in the formation of uterine fibroids. The article examines current data on the genetic determinants of uterine fibroids, obtained as a result of the analysis of full-genomic studies (GWAS) and subsequent replicative studies. At this point in time, materials from 8 GWAS and 5 replicative studies of uterine fibroids are presented in the literature. According to GWAS data, more than 50 different candidate genes involved in the development of the disease have been identified. However, only 19 genes (CDC42/WNT4, GREB1, ACTRT3/TERC/MYNN/LRRC34, SCFD2/LNX1, SULT1B1, TERT, FGFR4, SYNE1/ESR1, KANK1/ DMRT1, SLK/OBFC1, WT1/CD44/PDHX, BET1L/RIC8A/SIRT3/PSMD13, ATM/C11orf65, SLC38A2, LINC0/FOXO1/FLJ42392, SHBG/TP53, MCM8/TRMT6, TNRC6B, MED12/TEX11/SLC7A3) have shown an association with uterine fibroids in two or more GWAS studies. In 5 conducted replicative studies of uterine fibroids, the involvement in the formation of the disease was confirmed for only 2 (BET1L and TNRC6B) of more than 50 significant candidate genes for uterine fibroids known to date by GWAS. This dictates the need to continue further genetic and epidemiological studies of uterine fibroids in different ethno-territorial groups.
About the Authors
M. S. Ponomarenko
Belgorod State National Research University
Russian Federation
Russian Federation
Marina S. Ponomarenko, Postgraduate Student, Department of Biomedical Disciplines of the Medical Institute
85, Pobedy St., Belgorod, 308015
E. A. Reshetnikov
Belgorod State National Research University
Russian Federation
Russian Federation
Evgeny A. Reshetnikov, Dr. Sci. (Biol.), Associate Professor, Professor of the Department of Biomedical Disciplines of the Medical Institute
85, Pobedy St., Belgorod, 308015
I. V. Ponomarenko
Belgorod State National Research University
Russian Federation
Russian Federation
Irina V. Ponomarenko, Dr. Sci. (Med.), Associate Professor, Professor of the Department of Biomedical Disciplines of the Medical Institute
85, Pobedy St., Belgorod, 308015
M. I. Churnosov
Belgorod State National Research University
Russian Federation
Russian Federation
Mikhail I. Churnosov, Dr. Sci. (Med.), Professor, Head of the Department of Biomedical Disciplines of the Medical Institute
85, Pobedy St., Belgorod, 308015
References
1. Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022;43(4):678–719. https://doi.org/10.1210/endrev/bnab039.
2. Koltsova AS, Efimova OA, Pendina AA. A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity. Int J Mol Sci. 2023;24(6):5752. https://doi.org/10.3390/ijms24065752.
3. Alsudairi HN, Alrasheed AT, Dvornyk V. Estrogens and uterine fibroids: an integrated view. Res Result Biomed. 2021;7(2):156–163. https://doi.org/10.18413/2658-6533-2021-7-2-0-6.
4. Stewart EA, Nowak RA. Uterine Fibroids: Hiding in Plain Sight. Physiology (Bethesda). 2022;37(1):16–27. https://doi.org/10.1152/physiol.00013.2021.
5. Iashchuk AG, Musin II, Gumerova IA. Current aspects of the study of uterine myoma etiology. Russian Bulletin of Obstetrician-Gynecologist. 2019;19(3):49–56. (In Russ.) https://doi.org/10.17116/rosakush20191903149.
6. Aganezova NV, Aganezov SS, Shilo MM. Uterine fibroids: modern practical aspects of the disease. Russian Journal of Human Reproduction. 2022;28(4):97–105. (In Russ.) https://doi.org/10.17116/repro20222804197.
7. Lou Z, Huang Y, Li S, Luo Z, Li C, Chu K et al. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study. BMC Public Health. 2023;23(1):916. https://doi.org/10.1186/s12889-023-15765-x.
8. Ponomarenko IV, Churnosov MI. Current views on the etiopathogenesis and risk factors of uterine leiomyoma. Akusherstvo i Ginekologiya (Russian Federation). 2018;(8):27–32. (In Russ.) https://dx.doi.org/10.18565/aig.2018.8.27-32.
9. Välimäki N, Kuisma H, Pasanen A, Heikinheimo O, Sjöberg J, Bützow R et al. Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability. Elife. 2018;18(7):e37110. https://doi.org/10.7554/eLife.37110.
10. Cha PC, Takahashi A, Hosono N, Low SK, Kamatani N, Kubo M et al. A genomewide association study identifies three loci associated with susceptibility to uterine fibroids. Nat Genet. 2011;43(5):447–450. https://doi.org/10.1038/ng.805.
11. Hellwege JN, Jeff JM, Wise LA, Gallagher CS, Wellons M, Hartmann KE et al. A multi-stage genome-wide association study of uterine fibroids in African Americans. Hum Genet. 2017;136(10):1363–1373. https://doi.org/10.1007/s00439-017-1836-1.
12. Rafnar T, Gunnarsson B, Stefansson OA, Sulem P, Ingason A, Frigge ML et al. Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits. Nat Commun. 2018;9(1):3636. https://doi.org/10.1038/s41467-018-05428-6.
13. Edwards TL, Giri A, Hellwege JN, Hartmann KE, Stewart EA, Jeff JM et al. A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids. Front Genet. 2019;12(10):511. https://doi.org/10.3389/fgene.2019.00511.
14. Masuda T, Low SK, Akiyama M, Hirata M, Ueda Y, Matsuda K et al. GWAS of five gynecologic diseases and cross-trait analysis in Japanese. Eur J Hum Genet. 2020;28(1):95–107. https://doi.org/10.1038/s41431-019-0495-1.
15. Gallagher CS, Mäkinen N, Harris HR, Rahmioglu N, Uimari O, Cook JP et al. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nat Commun. 2019;10(1):4857. https://doi.org/10.1038/s41467-019-12536-4.
16. Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S et al. A cross- - population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415–1424. https://doi.org/10.1038/s41588-021-00931-x.
17. Wise LA, Ruiz-Narvaez EA, Palmer JR, Cozier YC, Tandon A, Patterson N et al. African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol. 2012;176(12):1159–1168. https://doi.org/10.1093/aje/kws276.
18. Edwards TL, Michels KA, Hartmann KE, Velez Edwards DR. BET1L and TNRC6B associate with uterine fibroid risk among European Americans. Hum Genet. 2013;132(8):943–953. https://doi.org/10.1007/s00439-013-1306-3.
19. Bondagji NS, Morad FA, Al-Nefaei AA, Khan IA, Elango R, Abdullah LS et al. Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas. J Obstet Gynaecol Res. 2017;43(2):330–338. https://doi.org/10.1111/jog.13217.
20. Liu B, Wang T, Jiang J, Li M, Ma W, Wu H et al. Association of BET1L and TNRC6B with uterine leiomyoma risk and its relevant clinical features in Han Chinese population. Sci Rep. 2018;8(1):7401. https://doi.org/10.1038/s41598-018-25792-z.
21. Lee SC, Chou YH, Tantoh DM, Hsu SY, Nfor ON, Tyan YS et al. Risk of uterine leiomyoma based on BET1L rs2280543 single nucleotide polymorphism and vegetarian diet. BMC Womens Health. 2022;22(1):139. https://doi.org/10.1186/s12905-022-01721-1.
22. Edwards TL, Hartmann KE, Velez Edwards DR. Variants in BET1L and TNRC6B associate with increasing fibroid volume and fibroid type among European Americans. Hum Genet. 2013;132(12):1361–1369. https://doi.org/10.1007/s00439-013-1340-1.
23. Tyan YS, Shen CY, Tantoh DM, Hsu SY, Chou YH, Nfor ON et al. Association between ESR1 rs2234693 single nucleotide polymorphism and uterine fibroids in Taiwanese premenopausal and postmenopausal women. J Health Popul Nutr. 2023;42(1):16. https://doi.org/10.1186/s41043-023-00357-7.
24. Ponomarenko I, Reshetnikov E, Polonikov A, Verzilina I, Sorokina I, Yermachenko A et al. Candidate Genes for Age at Menarche Are Associated With Uterine Leiomyoma. Front Genet. 2021;11:512940. https://doi.org/10.3389/fgene.2020.512940.
25. Ponomarenko IV, Polonikov AV, Churnosov MI. Polymorphic loci of the LHCGR gene are associated with the development of uterine leiomyoma. Akusherstvo i Ginekologiya (Russian Federation). 2018;(10):86–91. (In Russ.) https://doi.org/10.18565/aig.2018.10.86-91.
26. Demakova NA. Molecular and genetic characteristics of patients with hyperplasia and endometric polyps. Research Results in Biomedicine. 2018;4(2):26–39. (In Russ.) https://doi.org/10.18413/2313-8955-2018-4-2-0-4.
27. Ponomarenko MS, Reshetnikov EA, Churnosova MM, Reshetnikova YN, Churnosov VI, Ponomarenko IV. Comorbidity and syntropy of benign proliferative diseases of the female reproductive system: non-genetic, genetic, and epigenetic factors (review). Res Result Biomed. 2023;9(4):544–556. https://doi.org/10.18413/2658-6533-2023-9-4-0-9.
28. Radzinsky VE, Altuchova OB. Molecular-genetic determinants of infertility in genital endometryosis. Research Results in Biomedicine. 2018;4(3):28–37. (In Russ.) https://doi.org/10.18413/2313-8955-2018-4-3-0-3.
Review
For citations:
Ponomarenko MS, Reshetnikov EA, Ponomarenko IV, Churnosov MI. Molecular genetic factors of uterine fibroids formation. Meditsinskiy sovet = Medical Council. 2025;(4):21-25. (In Russ.) https://doi.org/10.21518/ms2025-051
Views:
119
Email this article 